Suchen
Scienture Holdings Inc
SCNXZur Watchlist hinzufügen
0.290USD
+0.005+1.75%
Handelsschluss 09-22 16:00（ET）
11.78MMarktkapitalisierung
VerlustKGV TTM
Über Scienture Holdings Inc Unternehmen
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
Scienture Holdings Inc Profil
BörsenkürzelSCNX
Name des UnternehmensScienture Holdings Inc
IPO-datumFeb 18, 2020
CEOHariharan (Shankar)
Anzahl der mitarbeiter14
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 18
Addresse- -
Stadt- -
BörseNASDAQ OMX - NASDAQ BASIC
Land- -
Postleitzahl- -
Telefon- -
Website- -
BörsenkürzelSCNX
IPO-datumFeb 18, 2020
CEOHariharan (Shankar)
Führungskräfte von Scienture Holdings Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
President, Co-Chief Executive Officer, Interim Chief Financial Officer, Director
2.95M
+64.35%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Scienture Holdings Inc?
Die fünf größten Anteilseigner von Scienture Holdings Inc sind: Dr. Narasimhan Mani
Wie viele Institutionen halten Anteile an Scienture Holdings Inc (SCNX)?
Mit Stand vom 2026Q1 halten 26 Institutionen Anteile an Scienture Holdings Inc, mit einem Gesamtmarktwert von etwa 2.00M, was 4.93% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 289959.00 gestiegen.